# Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer

> **NCT00919984** · PHASE2 · TERMINATED · sponsor: **Korea Cancer Center Hospital** · enrollment: 22 (actual)

## Conditions studied

- Ovarian Neoplasms

## Interventions

- **DRUG:** IP chemotherapy

## Key facts

- **NCT ID:** NCT00919984
- **Lead sponsor:** Korea Cancer Center Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** This study stopped due to slow accrual.
- **Last updated:** 2014-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00919984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00919984, "Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00919984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*